Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tremfya Shows Head-To-Head Edge Versus Stelara In Crohn’s

22 May 2024

• By Joseph Haas

Related Content

AbbVie’s Skyrizi Bests Stelara Head-To-Head In Crohn’s

12 Sep 2023

J&J's Tremfya Gets Its Blockbuster Wings

15 Oct 2019

First Phase III IBD Trial Reads Out Positive For Janssen’s Tremfya

09 May 2023

Related Companies

Johnson & Johnson

AbbVie Inc.

Additional Topics

Clinical Trials Business Strategies Drug Approval Standards Research & Development Gastrointestinal BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.